Grail Stock Jumps 55% After FDA Panel Supports Multi-Cancer Detection Test
Grail shares surged 55% through Friday morning after a favorable FDA advisory vote on its multi-cancer early detection test.
Iovance Shares Rally as Survey Points to Strong Amtagvi Demand in Melanoma
A proprietary analyst survey is lifting sentiment around IOVA, but its demand signal is not the same as confirmed sales or market-share data.
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
Abeona Shares Draw Buy Rating After FDA Approval of FAYUVI Gene Therapy
H.C. Wainwright reiterated a Buy rating on Abeona after FDA approval of partner Ultragenyx’s FAYUVI gene therapy for ped…
Eli Lilly Shares Rise 3.7% After FDA Clears Once-Weekly Onswik Insulin
FDA approval of once-weekly Onswik lifted LLY shares 3.73%, adding another pillar to Eli Lilly’s diabetes and metabolic-…
GoDaddy Stock Jumps 6% as Reported Gen Digital Takeover Interest Sparks Fresh M&A Focus
GoDaddy shares jumped about 6% after a report of takeover interest from Gen Digital, putting deal confirmation and terms…
MGM Resorts Stock Drops 9% After People Inc. Withdraws Takeover Offer
MGM Resorts shares fell 9% after People Inc. withdrew its offer, removing takeover-premium expectations and raising caut…
Eli Lilly Stock Nears $1,200 After Weekly Insulin Approval and $3.25 Billion InnoCare Deal
Eli Lilly shares reached $1,191.92 after FDA approval of weekly insulin Onswik and a $3.25 billion InnoCare agreement br…
Elmet Group's Strategic Move: Acquiring Stake in Tungsten Supply Amid Rising Demand
Elmet Group's $125 million acquisition signals a pivotal shift in the tungsten supply landscape for the U.S. market.
aTyr Pharma's FDA Protocol Alignment Sparks Pre-Market Surge: What Investors Need to Know
aTyr Pharma's stock jumped 9.8% in pre-market trading after FDA trial protocol alignment, highlighting a key milestone f…
Eli Lilly's Onswik Approval: A Game Changer for Diabetes Management and Investment Potential
Eli Lilly's recent FDA approval of Onswik represents a significant advancement in diabetes treatment and investment pote…
Alkami Technology Faces Selloff: Implications of Ending Its Strategic Review
Alkami Technology's decision to remain independent leads to a significant stock selloff, impacting fintech valuations.